Issue link: http://osercommunicationsgroup.uberflip.com/i/562613
O s e r C o m m u n i c a t i o n s G r o u p D e n v e r M o n d a y, A u g u s t 2 4 , 2 0 1 5 AN INDEPENDENT PUBLICATION NOT AFFILIATED WITH NACDS On February 24, 2015, Mayne Pharma announced the completion of the acquisition of the Doryx ® brand and related assets from Actavis. Since that time, it has established a U.S. Specialty Brands Division and added new staff and leadership to support the acquisition. Doryx (Doxycycline Hyclate Delayed-Release Continued on Page 77 MAYNE PHARMA ACQUIRES DORYX BRAND C i t r o n P h a r m a , h e a d q u a r - tered in East Brunswick, New Jersey, is a pri- vately held pharmaceutical company focused on developing and marketing both branded and generic products from diverse therapy segments. Citron's multi-therapy focus brings a wide portfolio of vital products to the market from the best of FDA-approved manufacturing facilities in the U.S. and India. Continued on Page 77 CHANGING HEALTH, WELLNESS DELIVERY R O C A S U B A , Inc, the creator of the beauty indus- try phenomenon R a p i d L a s h ® E y e L a s h E n h a n c i n g Serum, introduces RapidBrow ® Eyebrow Enhancing Serum and RapidHair™ Hair Volumizing Formula to chain drug, club and mass merchants nationwide. Until now, these products have only been sold into professional channel and limited specialty Continued on Page 85 ROCASUBA BRINGS HAIR SOLUTIONS TO RETAILERS An interview with Justin Brown, Vice President of Sales, TriCalm. CDD: TriCalm has grown a great deal over the past year. To what do you attribute that growth? JB: We've been very pleased. When we first introduced TriCalm we knew we had a Continued on Page 77 TRICALM: SOLVING ITCH IN A NEW WAY The Cetaphil ® brand of skin care products was recently awarded the honor of No. 1 Pharmacist Recommended brand for a third year in a row by Pharmacy Times and U.S. News & World Report in the Therapeutic Skin Care Cleansers category. The award was announced online and in the June issue of Pharmacy Times. According to Pharmacy Continued on Page 85 CETAPHIL NAMED NO. 1 PHARMACIST RECOMMENDED An interview with Bob Cunard, Chief E x e c u t i v e O f f i c e r , Aurobindo USA. CDD: Tell our readers about Aurobindo USA. BC: Aurobindo is a global generic pharmaceutical compa- ny, marketing products in more than 125 countries around the world. Although started as a Continued on Page 85 THE FUTURE IS BRIGHT FOR AUROBINDO An interview with Chris Arington, Chief E x e c u t i v e Officer, Prasco. CDD: Prasco utilizes a unique corporate tag line: Unlimit ® . What does that tag line commu- nicate about the Prasco's approach to business? CA: We coined the phrase "unlimit" in 2004. Although Continued on Page 84 PRASCO'S UNLIMIT APPROACH TO BUSINESS A problem/solu- tion approach has always been part of SheaMoisture's hair and skin care DNA. The collections contain efficacious natural ingredients, which are incorpo- rated into the formulations in traditional culturally authentic ways for maximum benefits. Firmly committed to "A Better Way To Beautiful," SheaMoisture products are made with natural and certified organic ingredients, not tested Continued on Page 84 SUNDIAL BRANDS TARGETS 'THE NEW GENERAL MARKET' An inter- view with S t e v e Roden, Senior Vice President Xerox Pharma & Life Sciences. CDD: What does Xerox do for the healthcare industry? SR: We're working behind the scenes to simplify healthcare in ways you might not expect. Xerox is one of the largest BPO providers to the healthcare industry with a very broad Continued on Page 84 XEROX AND THE HEALTHCARE INDUSTRY A ff o r d a b l e Care Act has been over- whelmingly successful at engaging consumers more directly in their healthcare pur- chases. Patients, now called consumers, are taking on addi- tional responsibilities under the ACA. But what does that mean? Let's cut through the noise and melee of free-market variables or simple cost shifting and dis- cern the opportunities – latent or exposed. Continued on Page 84 OPPORTUNITIES FROM DISRUPTION